Stribild, Single-Tablet HIV Regimen, Demonstrates Long-Term Viral Suppression

Positive long-term efficacy and safety results have been reported from two pivotal phase III studies of the once-daily single-tablet regimen Stribild in treatment-naive patients with human immunodeficiency virus-1 infection.

http://www.formkit.com/news/DailyDetail.cfm?chosen=67909